News & Events
News articles, press releases and events Innoblative is attending
Committed to innovative surgical solutions for improved tissue coagulation and ablation, enhancing patient care.
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it
Join Us at The 25th American Society of Breast Surgeons (ASBrS) 2024 Annual Meeting
When: April 10–14, 2024 Location: Orlando World Center Marriott, 8701 World Center Dr, Orlando, FL 32821 Learn more here
Join Us at the Society of Surgical Oncology (SSO) 2024 Annual Meeting
When: Mar 20-23 2024 Location: Georgia World Congress Center, Atlanta, GA 30313 Learn more here
Join Us at NYMBCG 50TH ANNUAL BREAST CANCER SYMPOSIUM: 2024
When: Mar 2, 2024, 7:30 AM – 3:45 PM Location: New York Academy of Medicine (NYAM), 1216 Fifth Avenue, New York, New York Find out
Innoblative Designs: Revolutionizing Post-Lumpectomy Treatment
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast
Innoblative Receives U.S. FDA Breakthrough Device Designation for its SIRA RFA Electrosurgical Device
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company
Innoblative Welcomes Kelly Londy as Chief Executive Officer
CHICAGO, Sept. 4, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, including its recently FDA cleared SIRA™ RFA
